UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Flemington Pharmaceutical Corporation
Common
33928010
Check the following box if a fee is being paid with this statement ( ).
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1; and (2) has
filed no amendment subsequent thereto reporting beneficial ownership of
give percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP NO. 33928010 13G
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SunTrust Banks, Inc. as Parent Holding Company for: SunTrust Banks of
Georgia, Inc. and in various fiduciary capacities. 58-1575035
- ------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) _______
(B) _______
- ------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Georgia
- ----------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 192,870
--------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY -0-
--------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 192,870
--------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH -0-
- ----------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
192,870
- ------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
- ------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.00%
- ------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
HC and BK
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Item 1(a) Name of Issuer:
- --------- --------------
Flemington Pharmaceutical Corporation
Item 1(b) Address of Issuer's Principal Executive Offices:
- --------- -----------------------------------------------
Attn: Mr. Robert F. Schaul, Corporate Secretary
43 Emery Avenue
Flemington, New Jersey 08820
Item 2(a) Name of Person Filing:
- --------- ---------------------
SunTrust Banks, Inc. as Parent Holding Company for: SunTrust
Banks of Georgia, Inc. and in various fiduciary capacities.
Item 2(b) Address of Principal Business Office(s):
- --------- ---------------------------------------
303 Peachtree Street, Suite 1500
Atlanta, Georgia 30308
Item 2(c) Citizenship:
- --------- -----------
SunTrust Banks, Inc. is a Georgia corporation; SunTrust
Banks of Georgia, Inc. is a Georgia corporation.
Item 2(d) Title of Class of Securities:
- --------- ----------------------------
Common
Item 2(e) CUSIP Number:
- --------- ------------
33928010
Item 3 Type of Person:
- ------ --------------
(b) Bank as defined in section 3(a)(6) of the Act.
(g) Parent holding company, in accordance with para. 240,13d-
1(1)(ii)(H).
Item 4 Ownership:
- ------ ---------
Amount Beneficially Owned. 192,870
(b) Percent of Class: 5.00%
(c) Number of Shares as to which such person has:
(i) Sole power to vote or to direct the vote: 192,870
(ii) Shared power to vote or to direct the vote: -0-
(iii) Sole power to dispose or to direct the disposition of:
192,870
(iv) Shared power to dispose or the direct the disposition
of: -0-
Item 5 Ownership of Five Percent or Less of Class:
- ------ ------------------------------------------
Not Applicable
Item 6 Ownership of More than 5 Percent of Behalf of Another Person:
- ------ ------------------------------------------------------------
See Exhibit B
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
------------------------------------------------------------
See Item 2 and Exhibit C
Item 8 Identification and Classification of Members of the Group:
- ------ ---------------------------------------------------------
Not Applicable
Item 9 Notice of Dissolution of Group:
- ------ ------------------------------
Not Applicable
Item 10 Certification:
- ------- -------------
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of of such securities and
were not acquired in connection with or as a participant in any
transaction having such purpose or effect.
Signature:
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Dated: March 23, 1998
SunTrust Banks, Inc.
By /s/ Cynthia S. Walker
-------------------------
Cynthia S. Walker, Assistant Vice President
STI Trust & Investment Operations, Inc. as agent for
SunTrust Banks, Inc.
EXHIBIT A
The shares reported are held by one or more bank subsidiaries of SunTrust
Banks, Inc., in various fiduciary and agency capacities. SunTrust Banks,
Inc. and such subsidiaries disclaim by beneficial interest in any of the
shares reported, and the filing of this statement shall not be construed as
an admission to the contrary.
Certain of the shares included in shared voting authority are held in
agency accounts and co-fiduciary accounts and co-fiduciary accounts
in nominee registration. These are voted by the banks under revocable
authority of trust accounts and therefore, are reported as shared
voting authority.
EXHIBIT B
Various co-trustees share the power to direct subsidiaries of income
including dividends and the proceeds from sale of securities.
Additionally, various beneficiaries have the right to receive
dividends.
EXHIBIT C
Sole Shared Sole Shared
Voting Voting Power to Power to
Name of Person Filing Power Power Dispose Dispose
SunTrust Banks of Georgia, Inc.
as Parent Holding Company for:
- ------------------------------
SunTrust Bank, West Georgia and 192,870 -0- 192,870 -0-
in Various Fiduciary Capacities
P.O. Box 431
Columbus, Georgia 31902
Shares Beneficially Owned 192,870
SunTrust Banks, Inc.
303 Peachtree Street, Suite 1500
Atlanta, Georgia 30308
March 23, 1998
Ladies and Gentlemen:
There is hereby transmitted for filing pursuant to Section 13(g) of the
Securities Exchange Act of 1934 and Rule 13G thereunder a Schedule 13G
relating to beneficial ownership by SunTrust Banks, Inc. and its subsidiaries
of shares of Flemington Pharmaceutical Corporation Common Stock.
Please call the undersigned at (404) 581-1475 if you have any questions.
Sincerely,
/s/ Cynthia S. Walker
- ---------------------
Cynthia S. Walker
Assistant Vice President
STI Trust & Investment Operations, Inc. as agent for SunTrust Banks, Inc.
cc: Flemington Pharmaceutical Corporation
